• • Once-weekly injection
• • Self-injectable weight loss treatment (GLP-1/GIP)
• • Licensed for weight loss
• • Suppresses appetite and prolongs satiety
• • Manufactured by Eli Lilly
• • Active ingredient: Tirzepatide
• • Average weight loss: ~15%–20%*

Mounjaro is a once-weekly, self-injectable prescription medication used for weight loss in adults with a BMI of 30 or above, or 27 and above with weight-related conditions. It works by activating hormones that help control appetite, regulate blood sugar, and reduce hunger.

Each pack of Mounjaro contains 4 x weekly doses + needles